
    
      Approximately 30 subjects (about 15 per treatment group),will be enrolled and randomized to
      receive either R-verapamil or placebo for 2 weeks. The study will consist of a 1-week run-in
      period and a 2-week treatment period (R-verapamil or placebo). The total duration of the
      study for each treatment group is 3 weeks.
    
  